News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides
NanoViricides reports progress in Phase IIA Ebola Treatment Clinical Trial for NV-387 Oral Gummies, evaluating dosage regimens and efficacy against Ebola Bundibugyo virus, with safety and tolerability focus -
-
COMMUNIQUÉ DE PRESSE
First Breach Completes First Autonomous Flight of Proprietary Drone Prototype
First Breach Inc. successfully completes first autonomous flight with their proprietary drone prototype. The company aims to offer advanced capabilities to defense and government customers, focusing on testing and preparing for American manufacturing -
COMMUNIQUÉ DE PRESSE
NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements
NioCorp partners with Traxys for commercial support of Elk Creek Project, securing 100% of planned production for 15 years. Exclusive rights agreement includes scandium, titanium, and rare earth products -